I have my quibbles with the Stelo app, but it’s still very early days and this is an emerging category. Speed bumps are to be expected. I plan to test the Stelo further, and I’m curious to see how my conversation with my doctor will go. Even so, from my time thus far,I can see how using Stelo, in concert with a doctor, could be helpful for people with prediabetes and Type 2 diabetes. What’s less clear is how the rest of the market will glom onto more widely accessible CGMs. Occasionally, I see wellness influencers peddling CGM use for weight loss and to “fix” metabolic health. Several startups exist based around that premise, even though we have yet to prove whether this is a worthy use for CGMs. We’ll have to see where this goes, but at the very least, I appreciate that Dexcom has kept its focus on the people who could most benefit from this tech — and at a more accessible price.